Generation Bio Co (GBIO) - News Archive

In a groundbreaking move within the biotechnology sector, Generation Bio Co. (Nasdaq: GBIO) is making strides in developing innovative therapeutics for T cell-driven autoimmune diseases. The company recently announced i...

The groundbreaking preclinical data on immunoquiet DNA (iqDNA) and cell-targeted lipid nanoparticle (ctLNP) platforms unfolded at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting by the revoluti...